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c-Aminobutyric acid (GABA) is considered to be the most important inhibitory neurotransmitter in the
central nervous system, including the retina. It has been shown that nitric oxide (NO) can inﬂuence
the physiology of all retinal neuronal types, by mechanisms including modulation of GABA release. How-
ever, until now, there have been no data concerning the effects on endogenous GABA release of NO pro-
duced by cells in the intact retina. In the present study, we have investigated how NO production induced
by drugs inﬂuences the release of endogenous GABA in cells of the intact retina of mature chicken.
Retinas were exposed to different drugs that affect NO production, and GABA remaining in the tissue
was detected by immunohistochemical procedures. A speciﬁc nNOS inhibitor (7-NI) reduced the number
of GABA + amacrine cells and cells in the ganglion cell layer (GCL) by 33% and 41%, respectively. A GABA
transporter inhibitor blocked this effect. L-arginine (100 lM), the precursor of NO, induced increases of
62% and 34% in the number of GABA + amacrine cells and GCL cells, respectively. A sodium (Na+)-free
solution, 7-NI and a PKG inhibitor prevented the effect of L-arginine (100 lM). However, a higher concen-
tration of L-arginine (1 mM) induced a 35% reduction in the number of GABA + cells by a Na+-dependent
mechanism that was restricted to the GCL population. NMDA, which stimulates NO production, increased
GABA release as indicated by 53% and 38% reductions in the number of GABA + amacrine cells and GCL
cells, respectively. This effect was blocked by 7-NI only in GCL cells. We conclude that basal NO produc-
tion and moderate NO production (possibly induced by L-arginine; 100 lM) inhibit basal GABA release
from amacrine cells and GCL cells. However, NMDA or L-arginine (1 mM) induce a NO-dependent increase
in GABA release in GCL cells, possibly by stimulating higher NO production.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
c-Aminobutyric acid (GABA) and glutamate are considered,
respectively, to be the most important inhibitory and exci-
tatory neurotransmitters in the central nervous system (CNS),
including in the retina of different animal species (Massey &
Redburn, 1987; Mosinger, Yazulla, & Studholme, 1986; Thoreson
& Witkovsky, 1999; Yazulla, Studholme, Vitorica, & De Blas,
1989). In the retina, the vertical pathway is formed by glutamater-
gic cells that transmit information from photoreceptors to bipolar
cells and then to ganglion cells, which are responsible for sending
the information to superior visual centers (Barnstable, 1993;
Massey & Maguire, 1995; Thoreson &Witkovsky, 1999). Horizontal
and amacrine GABAergic cells modulate the activity of the vertical
pathway, forming the lateral pathway (Barnstable, 1993; Sun &ll rights reserved.
e Neurobiologia, Instituto de
140 Niterói, Rio de Janeiro,Crossland, 2000; Tachibana & Kaneko, 1988; Yazulla, 1986). The
interaction between the glutamatergic vertical pathway and the
GABAergic lateral pathway is very important for the processing
of visual information in the retina, mainly for simultaneous
contrast.
According to Sun and Crossland (2000), almost 100% of amacrine
cells express GABA and/or glycine, and more than 60% are GABAer-
gic. Most GABAergic amacrine cells receive glutamatergic inputs
from bipolar cells (Marc & Liu, 2000). A number of investigators
used different methods to analyze GABA content of speciﬁc cell
populations in several species. From these studies, it was demon-
strated that L-glutamate and its analogues promote GABA release
via a calcium-independent and sodium (Na+)-dependent process,
in ﬁsh, amphibian, avian, and some mammalian retinas (Andrade
da Costa, De Mello, & Hokoç, 2000; Ayoub & Lam, 1984; Morán &
Pasantes-Morales, 1983; O’Malley and Masland, 1989; Tapia &
Arias, 1982; Yazulla, 1983; Yazulla & Kleinschmidt, 1982, 1983).
Nevertheless, a small amount of GABA release via a calcium-depen-
dent, probably vesicular exocytotic release seemed to take place
(Campochiaro, Ferkany, & Coyle 1985; Morán & Pasantes-Morales,
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calcium-independent mechanisms in other areas of the CNS
(Bernath & Zigmond, 1988; Schoffelmeer et al., 2000).
During the development of the 14-day-old embryonic (E14)
chick into the post-hatching (PE) animal, a major part of retinal
amacrine cells release GABA in response to the activation of NMDA
receptors, which form one class of ionotropic glutamate receptors
(iGluRs) (Calaza, De Mello, & Gardino, 2001; Calaza, Fialho De
Mello, Garcia De Mello, & Gardino, 2003). The NMDA receptor is
associated with nitric oxide synthase (NOS) through PSD-95, a 95
KDa postsynaptic density protein (Brenman et al., 1996). NOS
catalyzes the formation of nitric oxide (NO) and L-citruline from
L-arginine (Stuehr, 1999), and the activation of NMDA receptors
represents the main mechanism for NOS activation and NO pro-
duction in the CNS. In embryonic retinal cell cultures, activation
of NMDA receptors stimulates NO production, which induces
[3H]-GABA release (Ientile et al., 1997).
NO is a gaseous messenger molecule with many different func-
tions in the CNS, including modulation of neurotransmitter release
(Hirsch et al., 1993; Li, Chen, & Pan, 2002; Ohkuma, Narihara,
Katsura, Hasegawa, & Kuriyama, 1995; Prast & Philippu, 2001;
Segieth, Getting, Biggs, & Whitton, 1995; Trabace & Kendrick,
2000). It has been reported that NO stimulates GABA release in dif-
ferent CNS regions (Lonart, Wang, & Johnson, 1992; Ohkuma et al.,
1995; Segovia, Porras, & Mora, 1994; Ozaki et al., 2000; Li et al.,
2002; Saransaari & Oja, 2006; Segovia & Mora, 1998), including the
retina (Ientile et al., 1996; Ientile et al., 1997; Yu & Eldred, 2005).
NOS colocalization with GABA has been reported in the retina of
several species (Andrade da Costa et al., 2000; Haverkamp, Kolb, &
Cuenca, 2000; Oh, Kim, Lee, Chun, & Chung, 1998; Weiler & Kewitz,
1993). Oh and co-workers (1998) have shown that all NOS-immuno-
reactive neurons express GABA in the rat and rabbit retina.
It has been shown that NO modulates GABA release in a bipha-
sic way in different CNS regions (Getting, Segieth, Ahmad, Biggs, &
Whitton, 1996; Jayakumar et al., 1999; Paul & Ekambaram, 2005).
In the mouse hippocampus, GABA release is stimulated by NMDA-
mediated NO production or by a large dose of the NO donor SNAP
(1 or 2 mM). However, a lower concentration (500 lM) of the same
NO donor reduces GABA release (Getting et al., 1996), suggesting
that different NO concentrations might generate opposite effects.
Previous data suggest that NO may have an important role in
retinal visual processing. Accordingly, NO has been shown to inﬂu-
ence the physiology of all neuronal types in the retina. For instance,
NO decreases the strength of coupling of mGluR6 to downstream
elements in its signal transduction cascade pathway (Snellman &
Nawy, 2004), blocks gap junctions between horizontal cells
(Pottek, Schultz, & Weiler, 1997) and also junctions between AII
amacrine cells and cone bipolars cells (Mills & Massey, 1995).
Moreover, lack of nNOS reduces the sensitivity of ganglion cells
to light (Wang, van der List, Nemargut, Coombs, & Chalupa, 2007).
These many actions of NO in the retina could possibly be due to
modulation of neurotransmitter release. However, until now, there
have been no data about the effects of cell-derived NO on endoge-
nous GABA levels. Moreover, such modulation was not studied in
the intact chicken retina, which preserves cell connections and tis-
sue environment.
In the present study, we have investigated the modulation of
endogenous GABA release by NO in the mature chick intact retina.2. Materials and methods
2.1. Reagents and drugs
L-arginine, L-glutamate, glycine, polyclonal rabbit primary anti-
serum against GABA, gelatin, diaminobenzidine, NMDA and EDTAwere obtained from Sigma (St. Louis, MO, USA). Biotinylated goat
anti-rabbit IgG and avidin–biotin complex were obtained from
Vector. KT5823 was purchased from Calbiochem (San Diego, CA,
USA), 7-NI from Biomol (Plymouth Meeting, PA, USA) and NO-
711 (RBI). Other reagents were bought from common commercial
sources.2.2. Animals
FertilizedWhite Leghorn eggs were obtained from a local hatch-
ery. The procedures for the use of animals were in accordance with
the ‘‘NIH guide for the Care and Use of Laboratory Animals” and ap-
proved (# IBCCF001) by the commission of animal care (CEUA-CCS)
of the Centro de Ciências da Saúde of Federal University of Rio de
Janeiro.2.3. Tissue stimulation
For all experiments the animals were sacriﬁced, at the same
period of the day, by decapitation and then the eyes were enucle-
ated. In each experiment we used only one animal and each retina
was divided into two pieces, designated randomly as ‘‘control” or
as ‘‘experimental”. In addition, we used at least three different ani-
mals for each treatment. Retinas were incubated in Locke’s solu-
tion (157 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 1 mM MgCl2,
3.6 mM Na2HCO3, 5.0 mM HEPES and 5.6 mM glucose) or Hanks’
solution (128 mM NaCl, 4 mM KCl, 1 mM MgCl2, 3 mM CaCl2,
4 mM glucose, 20 mM HEPES) balanced with 95% O2/5% de CO2,
and pH adjusted to 7.2–7.4 with HCl 1 N and NaOH 1 N solutions
(or LiOH 1 N in experiments in which Na+ was suppressed). During
the stimulation period, retinas were kept in a bath solution at 37 C
with frequent shaking.
Retinal pieces were incubated in 500 lL of Locke’s or Hanks’
solution (control) or in the same solutions containing one of the
following drugs that affect NO production: the speciﬁc nNOS inhib-
itor, 7-nitroindazole (7-NI 100 lM) for 25 min; a substrate for NO
production, L-arginine (100 lM, 500 lM or 1 mM) for 25 min –
incubation with L-arginine was also performed without Na+,
whereupon the ion was replaced by lithium; and NMDA receptor
agonist, NMDA (100 lM), for 30 min. Experiments with NMDA
were performed in the absence of MgCl2, and in the presence of
the divalent cation chelator, EDTA (2 mM), and with glycine
(2 mM).
Some retinal pieces were pre-incubated with one of the follow-
ing compounds: NOS inhibitor (7-NI 100 lM) for 10 min; GABA
transporter inhibitor (NO-711 100 lM) for 20 min; and cyclic
GMP-dependent protein kinase (PKG) inhibitor (KT5823, 1 lM)
for 10 min. The drugs used during the pre-incubation period were
maintained during the following 25-min period of incubation with
L-arginine.2.4. Tissue ﬁxation
Immediately after tissue stimulation, retinal segments were
ﬁxed by immersion in 4% paraformaldehyde (diluted in 0.16 M
phosphate buffer (PB), pH 7.2) for 2 h. The segments were rinsed
with PB and then cryoprotected in sucrose (15% and 30%). After
24 h, retinas were mounted in OCT embedding medium (Sakura
Finetek, Torrance, CA), frozen, and cryosectioned. Sections perpen-
dicular to the vitreal surface (10–12 lm) were collected from the
whole retina onto gelatinized slides. Sections of control tissue
and from different treatment conditions were collected on the
same glass slide to avoid differences during immunohistochemical
procedure.
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Slides with sections of control and experimental retinas were
ﬁrst washed in sodium phosphate-buffered saline (PBS). Then,
the tissue was pre-incubated with 2% bovine serum albumin
(BSA) for 1 h, and incubated overnight with polyclonal rabbit pri-
mary antiserum against GABA (1:4000; Sigma). After several rinses
in PBS, the sections were incubated with biotinylated goat anti-
rabbit IgG (1:200; Vector) for 2 h. Further washes in PBS were
made and the sections incubated with a complex of biotin–avidin
(1:50; Vectastain Elite, Vector) for 1 h 30 min. Finally, sections
were rinsed in PBS twice for 10 min and incubated with 0.05%
3,3-diaminobenzidine and 0.01% hydrogen peroxide solution for
10 min. After three rinses, the slides were mounted with glycerol
(40% in PB). Immunohistochemical control sections were incubated
with PBS or rabbit normal serum in the absence of primary anti-
body, and no immunoreactivity was detected.2.6. Cell quantiﬁcation
Quantiﬁcation of the GABA-immunoreactive cell number was
possible because, in all experiments, control and experimental
groups were processed for immunohistochemistry in the same
slide and treated with all reagents at the same time and under
the same conditions. Therefore, there were no differences in the
histological or immunohistochemical procedures between control
and experimental retinas. All sections were examined and studied
under light microscopy (Axioskop microscope, Zeiss) and photo-
graphed with Nikon 80i.
Cells were considered GABA-positive (GABA+) when their stain-
ing was clearly distinguished from the background, i.e., generally
the staining in the upper part of the INL (where Müller and bipolar
cell bodies are localized), which does not show GABA-immunore-
activity in the chick retina.
We counted GABA + cells localized at the ganglion cell layer
(GCL) and at the ﬁrst three cell body tiers of the inner portion of
the INL, the region in which amacrine cells are found. We analyzed
these cell types because they are the chicken retinal GABAergic cell
subpopulations that produce NOS (Fischer & Stell, 1999). The total
numbers of amacrine cells and of cells in the GCL were always ob-
tained from six ﬁelds/section of at least three sections for each ret-
inal treatment in each experiment. In addition, in each experiment,
at least 190 cells in the GCL and 570 cells along three rows of cell
bodies in the innermost part of the inner nuclear layer were
counted in each control retina. Also, we used at least three differ-
ent animals for each treatment. We adjusted the microscope focus
in order to see cells more clearly, and we found about two or three
different focuses in which we could identify and count cells accu-
rately. The data were analyzed statistically using one-way ANOVA
and the Bonferroni Post-test. Data are shown as mean ± standard
error of the mean (mean ± SEM).3. Results
In agreement with previous results in the chick retina (Calaza
et al., 2001), no differences were observed between GABA-immu-
noreactivity patterns in tissue ﬁxed immediately after dissection
and in retinal pieces incubated in Locke’s solution (not illustrated).
GABA-containing cells were mainly distributed in the three inner-
most layers of somata in the inner nuclear (INL) and ganglion cell
layers (GCL). In addition, GABA-immunoreactive horizontal cells
were also observed, always constituting a single row of cells. The
IPL also showed an intense GABA-immunolabelling (Figs. 1A–5A).
Treatment with a nNOS inhibitor (7-NI) induced a 33% decrease
in GABA + amacrine cell number (Fig. 1B and D) and a 41% decreasein GABA + cell number in the GCL (Fig. 1B and E) in comparison to
the control (Fig. 1A). The effect of 7-NI was probably to be due to an
increase in GABA efﬂux, since it was blocked by NO-711, a selective
neuronal GABA transporter (GAT1) inhibitor (Fig. 1C–E). Thus, it
seems that when 7-NI inhibited basal NO production, it increased
GABA efﬂux and, consequently, reduced the GABA + cell number.
NO synthesis is induced by providing L-arginine to cells, since
L-arginine is the precursor for NO production by NOS (Kakuda,
Finley, Maruyama, & MacLeod, 1998; Kurz & Harrison, 1997;
Nicholson,Manner, Kleeman, &MacLeod 2001). Paul and Jayakumar
(1999) reported a signiﬁcant increase of NO levels in rat brains
treated with a high, but not a low, concentration of L-arginine, sug-
gesting that different concentrations of L-arginine would produce
distinct levels of NO. Therefore, we decided to test the effects of
different L-arginine concentrations on GABA release. When the ret-
ina was exposed to 100 lM L-arginine for 25 min, we veriﬁed 62%
and 34% increases in GABA + amacrine cell number (Fig. 2B and D)
and GABA + cell number in the GCL (Fig. 2B and E), respectively, in
comparison to control (Fig. 2A). The effect of L-arginine was specif-
ically due to NO production, since it was blocked by 7-NI (Fig. 2F
and G). The fact that L-arginine induces an increase in GABA + cell
number (Fig. 2B) is in agreement with the reduction in GABA + cell
number induced by 7-NI treatment in the cells of the GCL and INL
(Fig. 1B).
These data suggested that both basal and moderate levels of NO
production (the latter induced by 100 lM L-arginine) inhibit GABA
release. On the other hand, higher concentrations of L-arginine,
500 lM (data not shown) or 1 mM, did not affect the number of
GABA + amacrine cells (Fig. 2C and D). In the GCL, 500 lM L-argi-
nine also did not alter the number of GABA + cells (data not
shown), but 1 mM L-arginine induced a 35% reduction in GABA + -
cell number (Fig. 2C and E) compared to the control (Fig. 2A).
Therefore, these data support the idea that GABA release is induced
by higher NO levels in GCL cells, and it is reasonable to suggest that
1 mM L-arginine could produce such levels of NO.
The data also suggest a biphasic modulation of GABA release by
NO in cells of the GCL, and that such modulation would depend on
the NO concentration achieved.
In the retina, the main mechanism of GABA release is the rever-
sal of the GABA transporter (Calaza, Gardino, & De Mello, 2006;
Calaza et al., 2001; Carvalho, Ferreira, Carvalho, & Duarte, 1995;
Do Nascimento & De Mello, 1985; Duarte, Ferreira, Santos, Oliveira,
& Carvalho, 1993; Ferreira, Duarte, Santos, & Carvalho, 1994;
Morán & Pasantes-Morales, 1983; Schwartz, 1987; Tapia & Arias,
1982; Yazulla, 1983; Yazulla & Kleinschmidt, 1983). In order to
investigate if the effects of 100 lM and 1 mM L-arginine on GABA
efﬂux involve the modulation of the Na+-dependent GABA trans-
porter, retinas were exposed to a Na+-free Ringer for 25 min. The
absence of Na+ blocked the effects of the previously mentioned
concentrations of L-arginine (Fig. 3C and D), supporting the idea
that NO modulates GABA efﬂux that is induced by reversal of the
transporter.
Since NO can activate intracellular pathways that stimulate
cyclic GMP-dependent protein kinase (PKG) (Linden, Dawson, &
Dawson, 1995), we decided to study the involvement of the NO/
PKG pathway in the modulation of the GABA transporter by NO
production induced by L-arginine (100 lM). Retinas were treated
with the PKG inhibitor KT5823 (1 lM) and incubated with or with-
out L-arginine (100 lM). KT5823 blocked the expected L-arginine
(100 lM)-induced increase in the number of GABA + amacrine
cells (Fig. 4C and D) and the number of GABA + cells in the GCL
(Fig. 4C and E). However, KT5823 had no effect when incubated
alone (Fig. 4D and E), suggesting that the inhibitory effect in the
GABA transporter by moderate NO levels, probably induced by
100 lM L-arginine, depends on the NO-PKG pathway, whereas
the effect of basal NO does not.
Fig. 1. GABA release induced by nNOS inhibitor in INL and GCL cells. (A–C) Photomicrographs of GABA-immunoreactive cells in radial sections of the chick retina under
different treatments. (A) Control retina maintained in Locke’s solution. (B) GABA-immunoreactivity in retina treated with 100 lM7-NI showing fewer GABA + cells in INL, GCL
and reduction in the density of labeled processes in the IPL. (C) GABA-immunoreactivity in retina treated with 100 lM 7-NI + 100 lM NO-711. NO-711 blocked 7-NI effect.
Scale bar = 20 lm. (D–E) Histograms of the percentage of GABA + cells related to 100% of amacrine cell (D) or GCL cell (E) controls (For quantiﬁcation details, see Methods).
Values represent mean ± SEM. p < 0.01 with respect to control. N = 3 experiments were performed in triplicate. 100% of control corresponds to 960 ± 85 (mean ± SEM)
amacrine cells (D) and 261 ± 38.7 cells in the GCL (E) counted in control retina. INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. The same
abbreviations are used for all following ﬁgures. CTR, control; 7-NI, speciﬁc nNOS inhibitor; NO-711, speciﬁc inhibitor of the neuronal GABA transporter.
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by calcium inﬂux through NMDA receptors, which form a postsyn-
aptic complex with nNOS assembled by PSD-95 (Brenman et al.,
1996). In the present study, retinas treated with NMDA (100 lM)
for 30 min showed a reduction in GABA + amacrine cell number
(53%, Fig. 5B and D) and GABA + cell number in the GCL (38%,
Fig. 5B and E) in comparison to control retinas (Fig. 5A). Treatment
with the NOS inhibitor 7-NI (100 lm) during NMDA incubation
blocked the NMDA effect on GCL cell somas (Fig. 5C and E), but
not the effect on amacrine cell somas (Fig. 5C and D). This result
indicates that GABA efﬂux induced by NMDA is only mediated by
NO in the GCL, but not in amacrine cells. Also, this is in agreement
with the data showing that 1 mM L-arginine induces GABA efﬂux
only in the GCL, and supports the hypothesis that the GABA efﬂux
induced by NO in GCL cells depends on high levels of NO, probably
produced by 1 mM L-arginine or NMDA receptor activation.
4. Discussion
In this work, we found that NO can differently modulate GABA
release in distinct cell populations of the mature retina. In ama-
crine cells, basal or moderate NO levels inhibit tonic GABA release,
but high NO levels do not have any effect on endogenous GABA re-
lease. In GCL cells, as in amacrine cells, the same modulation by ba-
sal or moderate NO levels occurs; however, high NO levels increase
GABA release.
The NO effect on GABA release seems to be due to its capacity to
modulate Na+-dependent GABA transporter reversal. Several stud-
ies have shown that GABA release in the retina of several species
occurs mainly via a calcium-independent and Na+-dependent pro-
cess (Andrade da Costa et al., 2000; Ayoub & Lam, 1984; Morán &
Pasantes-Morales, 1983; O’Malley and Masland, 1989; Schwartz,
1982; Tapia & Arias, 1982; Yazulla, 1983; Yazulla & Kleinschmidt,1982, 1983). The possibility that NO could be modulating GABA
uptake was ruled out, because if the 1 mM L-arginine and 7-NI ef-
fects were due to inhibition of GABA uptake, then the blockade of
GABA transporter should not interfere with the results. As high-
lighted above, this was not the case, since the incubation in Na+-
free Ringer or NO-711 blocked the decrease in the number of
GABA-positive cells induced by, respectively, 1 mM L-arginine or
7-NI treatment. Taken together, our results suggest that the NO ef-
fect was mostly due to modulation of GABA efﬂux, through reversal
of the GABA transporter, rather than GABA uptake.
4.1. NO mechanisms of GABA metabolism modulation
Besides modulating GABA release, NO can also modulate GABA
synthesis in the retina. In the chick retina, a NO donor (SNAP) re-
duced by more than 60% the activity of glutamic acid decarboxyl-
ase (GAD), the enzyme responsible for GABA synthesis (Almeida
et al., 2002). NO can also regulate GABA degradation in some re-
gions of the CNS (Jayakumar et al., 1999; Paul & Ekambaram,
2005; Paul & Jayakumar, 1999), but such modulation has not been
veriﬁed in the retina yet. In our work, NO-induced increase or de-
crease in GABA + cells was totally blocked by an inhibitor of the
GABA transporter or by incubation in Na+-free solution. These re-
sults in the post-hatched chick retina suggest that the NO effect
was mostly due to modulation of GABA release, through reversal
of the GABA transporter, rather than a reduction in its degradation
or synthesis.
4.2. Biphasic effect of NO
NO has been reported to be both proconvulsant (Bagetta,
Iannone, Scorsa, & Nisticò 1992; DeSorro, Di Paola, Sarro, & Vidal,
1993; Mollace, Bagetta, & Nistic, 1991) and anticonvulsant (Penix,
Fig. 2. Effect of L-arginine, a substrate for NO production, on GABA + cells in the INL and GCL. (A–C) Photomicrographs of GABA-immunoreactive cells in radial sections of the
chick retina under L-arginine (L-arg) treatment. (A) Control retina maintained in Locke’s solution. (B–C) GABA-immunoreactivity in retinas treated with: (B) 100 lM L-arg,
showing an increase in the number of GABA + cells in INL and GCL; (C) 1 mM L-arg, showing a decrease in the GABA + cells in GCL. Scale bar = 20 lm. Histograms of
GABA + cell percentages related to 100% of amacrine cell (D–F) or GCL cell (E–G) controls (For details of quantiﬁcation see Methods). Values represent mean ± SEM. p < 0.05;
p < 0.001 with respect to control. CTR, N = 12 (100% of control corresponds to, mean ± SEM, 576 ± 75 amacrine cells (D–F) and 193 ± 19.8 cells in the GCL (E–G) counted in
control retinas); L-arg (100 lM), N = 12; L-arg (1 mM), N = 3; L-arg + 7-NI, N = 3; 7-NI, N = 3. All experiments were performed in triplicate. CTR, control; L-arg, L-arginine, a
substrate for NO production by NOS; 7-NI, speciﬁc nNOS inhibitor.
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1994). Segieth and collaborators (1995) reported that in rat hippo-
campus, the NO donor SNAP (500 lM) decreases tonic in vivo glu-
tamate release, but higher concentrations of SNAP (1–2 mM)
increases glutamate release. The same group also showed a similar
biphasic effect of the NO donor SNAP on GABA release (Getting
et al., 1996) and suggested that the NO biphasic effect on gluta-
mate and GABA release would explain those data that show both
an excitatory and an inhibitory action of the molecule. In our re-
sults, a NO biphasic effect on GABA + cell number was also veriﬁed.
Our data show that basal NO production inhibits tonic GABA re-
lease in GCL cells and topic amacrine cells, since the decrease in NO
production caused by 7-NI, a selective inhibitor of nNOS, reduced
the GABA + cell number. This effect seems to involve GABA release,
since it was blocked by NO-711, a selective inhibitor of the neuro-
nal GABA transporter. Additionally, retinal stimulation with
100 lM L-arginine, the substrate for NO production, induces anincrease in the GABA + cell number. This effect was apparently
due to an L-arginine-triggered production of NO, once it was
blocked by 7-NI. The 100 lM L-arginine effect was also blocked
by a Na+-free Ringer, indicating that the effect of augmenting NO
production by 100 lM L-arginine involves inhibition of Na+-depen-
dent, transporter-mediated GABA release. A negative regulation of
GABA signaling by NO in the retina has already been shown by
Wexler, Stanton, and Nawy (1998), whose study found that NO de-
presses GABAA receptor function.
In contrast, the treatment with a high concentration of L-argi-
nine (1 mM) decreased GABA + cell number in the GCL, but not in
the INL-localized amacrine cells. A Na+-free Ringer blocked this ef-
fect, indicating that the effect of augmenting NO production by
1 mM L-arginine involves transporter-mediated GABA release
(Calaza et al., 2001; Tapia & Arias, 1982; Yazulla & Kleinschmidt,
1982). We also propose that, as in the hippocampus (Getting
et al., 1996), NO exerts a biphasic modulation of GABA release in
Fig. 3. NO produced by 100 lM L-arginine inhibits GABA release via GABA transporter reversal. Photomicrographs of GABA-immunoreactive cells in radial sections of the
chick retina following treatment with or without Na+ in the medium. (A) Control retina maintained in Locke’s solution. (B) Control retina in Locke’s solution without Na+ in the
medium showing a similar GABA-immunoreactivity pattern. (C) Retina treated with 100 lM L-arg in the absence of Na+. Scale bar = 20 lm. (D–E) Histograms of GABA + cells
percentage related to 100% of amacrine cell (D) or GCL cell (E) controls (For quantiﬁcation details, see Methods). Values represent mean ± SEM. p < 0.05; p < 0.001 with
respect to control. (D) CTR, N = 6 (100% of control corresponds to, mean ± SEM, 594 ± 199 amacrine cells counted in control retinas); L-arg (100 lM), N = 6; L-arg (1 mM), N = 3;
CTR – Na+, N = 5 (100% of control corresponds to, mean ± SEM, 774 ± 42 amacrine cells counted in control retinas in Na+-free Ringer); L-arg (100 lM) – Na+, N = 5; L-arg (1 mM)
– Na+, N = 4. (E) CTR, N = 9 (100% of control corresponds to, mean ± SEM, 202 ± 3.4 cells of the GCL counted in control retinas); L-arg (100 lM), N = 9; L-arg (1 mM), N = 3; CTR –
Na+, N = 3 (100% of control corresponds to, mean ± SEM, 250 ± 28 cells of the GCL counted in control retina in Na+-free Ringer); L-arg (100 lM/1 mM) – Na2+, N = 3. All
experiments were performed in triplicate. CTR, control; L-arg, L-arginine; – Na+, Na+-free Ringer.
R.S. Maggesissi et al. / Vision Research 49 (2009) 2494–2502 2499GCL cells. GABA release was inhibited by basal and moderate NO
levels, but was induced by higher NO levels. On the other hand,
GABAergic topic amacrine cells in the INL are only negatively mod-
ulated by basal or moderate NO production. Consequently, in the
retina, it could be suggested that the overall amount of neuronal
excitability may depend on the concentration of NO modulating
GABA release.
4.3. NO production by NMDA receptor activation
Exposure of chick embryo retinal cells to low (10 lM) or high
(100 lM) concentrations of NMDA increases NOS activity, by,
respectively, 0.5- or 6-fold (Ientile et al., 1997). Therefore, our data
showing a reduction of NMDA (100 lM)-evoked GABA release
from GCL cells by NO is probably due to a high NO production after
NMDA receptor stimulation. In addition, NMDA-induced GABA re-
lease was blocked by 7-NI in cells of the GCL, but not in topic ama-
crine cells. This result supports the idea that the modulation of
GABA release by higher levels of NO occurs only in GCL cells. The
decrease of GABA-immunoreactivity in retinas exposed to NMDA
is not due to an eventual GABA leakage from damaged cells, but
probably due to transporter-mediated neurotransmitter release,
as we have previously shown (Calaza et al., 2001).
4.4. Mechanisms of GABA release modulation by NO
Yu and Eldred (2005) reported that a NO donor increased the re-
lease of GVG, a GABA analogue, from horizontal and amacrine cells
in the intact turtle retina. Additionally, Ientile and co-workers
(1997) demonstrated an increase in [3H]-GABA release inducedby a NO donor in chick embryo retinal cell cultures. They also ob-
served that [3H]-GABA release induced by NMDA receptor activa-
tion depends on NO production. The difference between these
reports and ours could be explained by the different methodologies
used. For instance, NO released by a NO donor may not be equiva-
lent to NO production by the cell, especially with respect to the
time and concentration of the production of this molecule. Unpub-
lished data from our group showed that a 500 lM NO donor
(SNAP) treatment for 60 min is necessary to achieve the same ef-
fect as treatment with 100 lM L-arginine for 25 min. This indicates
how different treatments can generate variable availability of NO.
Thus, since NO produced by donors or from substrates (e.g. L-argi-
nine) may have distinct kinetics of production or availability, cau-
tion should be taken when comparing their effects. Also, GABA
taken up by exogenous sources is not necessarily in the same pool
as GABA synthesized by the cell (Campochiaro, Ferkany, & Coyle,
1984). Yu and Eldred (2005) have also raised the possibility that
distinct NO effects on speciﬁc neurons can be explained by three
other factors: the availability of NO target molecules in a particular
neuron, the synaptic connections of the neuron and the physiolog-
ical oxidation state of the neuronal microenvironment. Here, we
investigated for the ﬁrst time the modulation of endogenous GABA
release by nitric oxide produced by the intact chick retina (ex vivo
preparation). Indeed, NO effects on GABA release depend on the le-
vel of NO production and also on the cellular type.
The mechanism of inhibition of tonic GABA release induced by
the basal NO level is different from that stimulated by moderate
levels of NO. In agreement with this idea, an inhibitor of PKG
(KT5823) blocked the 100 lM L-arginine-mediated inhibition of
GABA release but not the effect of basal NO. This suggests that
Fig. 4. Inhibition of GABA release by NO, produced by 100 lM L-arginine, depends on PKG activation. (A–C) Photomicrographs of GABA-immunoreactive cells in radial
sections of the chick retina. (A) Control retina maintained in Locke’s solution. (B) 100 lM L-arg showing an increase in the number of GABA-immunoreactive cells in INL and
GCL. (C) 100 lM L-arg + 1 lM KT5823 showing a blockade of the L-arg effect. Scale bar = 20 lm. (D–E) Histograms of GABA + cell percentages related to 100% of amacrine cell
(D) or GCL cell (E) controls (For quantiﬁcation details, see Methods). Values represent mean ± SEM. p < 0.001 with respect to control. CTR, N = 12 (100% of control
corresponds to, mean ± SEM, 576 ± 75 amacrine cells (D) and 193 ± 19.8 cells in the GCL (E) counted in control retinas); L-arg (100 lM), N = 12; L-arg + KT, N = 3; KT, N = 3. All
experiments were performed in triplicate. CTR, control retinas; L-arg (L-arginine); KT (KT5823), PKG inhibitor.
Fig. 5. GABA release induced by NMDA is mediated by NO production in the GCL. Photomicrographs of GABA-immunoreactive cells in radial sections of the chick retina. (A)
Control retina maintained in Locke’s solution. (B–C) GABA-immunoreactivity in retinas treated with: (B) 100 lMNMDA showing fewer GABA-immunoreactive cells in the INL
and GCL, and a drastic reduction in the density of labeled processes in the IPL; (C) 100 lM NMDA + 100 lM 7-NI. 7-NI blocked the NMDA effect in GCL cells but not in
amacrine cells. Scale bar = 20 lm. (D–E) Histograms of GABA + cell percentages related to 100% of amacrine cell (D) or GCL cell (E) controls (For quantiﬁcation details, see
Methods). Values represent mean ± SEM. p < 0.05; p < 0.01; p < 0.001 with respect to control. CTR, N = 5 (100% of control corresponds to (mean ± SEM) 693 ± 91.9
amacrine cells (D) and 240 ± 32 cells in the GCL (E) counted in control retinas); NMDA, N = 5; 7-NI, N = 3; NMDA + 7-NI, N = 3. All experiments were performed in triplicate.
CTR, control; NMDA, NMDA receptor agonist; 7-NI, speciﬁc nNOS inhibitor.
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whereas moderate NO production, stimulated by 100 lM L-argi-
nine, inhibits tonic GABA release through the activation of PKG.
Supporting the idea that NO can act through different pathways
depending on speciﬁc cell populations, it has been previously
shown that a NO donor stimulates GVG release from horizontal
cells primarily through a cGMP-mediated pathway, whereas in
amacrine cells, peroxynitrite plays a larger role (Yu & Eldred,
2005). In agreement with these ﬁndings, we found that the in-
crease in GABA release induced by high NO production following
treatment with 1 mM L-arginine occurs only in cells in the GCL,
however the mechanism remains unclear.
Although activation of the calcium-dependent protein kinase
(PKC) could inhibit the GABA transporter 1 (GAT1) (Beckman,
Bernstein, & Quick, 1998; Cristóvão-Ferreira, Vaz, Ribeiro, &
Sebastião, 2009; Gomeza, Casado, Gimenez, & Aragon, 1991), the
role of PKC and the relationship to PKG activation in our experi-
ments remain to be clariﬁed.4.5. NO effects on visual responses
It has already been described that an increase or decrease of
NO production can have powerful effects on visual responses.
Whole cell current-clamp recordings from ganglion cells of the
ferret retina treated with 5 mM L-arginine showed a reduction in
ON-responses, and also a complete blockage of APB-sensitive rod
OFF-responses (Wang, Liets, & Chalupa, 2003). Similar results were
found in the mouse retina (Wang, 2006). On the other hand, sensi-
tivity to light was also decreased in nNOS knockout retina. The
threshold of light intensities required to evoke optimal responses
was signiﬁcantly higher in the nNOS knockouts than in the wild-
type retina (Wang et al., 2007). The mechanisms underlying mod-
ulation of ganglion cells sensitivity by NO are not known, but seem
to be related to the regulation of retinal function by NO. As we have
reported here, basal NO production is necessary to maintain the
normal, tonic GABA release, and the same is required to promote
normal visual responses (Wang, 2006; Wang et al., 2003, 2007).
Here, we have demonstrated that different NO levels regulate
GABA release in a biphasic way, however it remains unclear exactly
how GABA release induced by different concentrations of NO inter-
feres with visual responses.Acknowledgments
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